Madrigal Pharmaceuticals, Inc. (MDGL)

513.72 -3.67 (-0.71%) USD  |  NASDAQ  |  May 01, 16:00
511.99 -1.73 (-0.34%) Pre-Market: 08:21
More

Madrigal Pharmaceuticals Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
PTC Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade